22 Jan 2026Open access
Allogreffe decellules souches hématopoïétiques dans les leucémies aigues myéloblastiques de l’enfant: Survieet rechutePublisher siteLa Tunisie Médicale, Hematopoietic Stem Cell Transplantation
Active, last published 2026
In hematopoietic stem cell transplantation
Saloua
Ladeb
Scholar“Research focused on Hematopoietic Stem Cell Transplantation and adjacent fields.”
University of Tunis El Manar
Tunisia
Claim Your ProfileTunisia17
H-index
1.2k
Citations
Saloua has not officially claimed their profile. If you are Saloua, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
aloua Ladeb is a researcher working on Hematopoietic Stem Cell Transplantation. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Saloua's work has been cited 1,170 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Hematopoietic Stem Cell Transplantation×43Acute Lymphoblastic Leukemia research×14Multiple Myeloma Research and Treatments×13Central Venous Catheters and Hemodialysis×12Acute Myeloid Leukemia Research×11
04 · Where I am
Affiliations
Affiliation on published researchTunis El Manar University, TunisiaDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
4 works16 Jul 2024
Cyclophosphamide and horse anti-thymocyte globulin versus fludarabine, reduced cyclophosphamide and rabbit anti-thymocyte globulin conditioning regimen for allogeneic hematopoietic stem cell transplantation from matched sibling donors in patients with acquired aplastic anemiaPublisher siteExpert Review of Hematology, Hematopoietic Stem Cell Transplantation
8 Feb 2024Open access
Immunogenicity and Tolerance of BNT162b2 mRNA Vaccine in Allogeneic Hematopoietic Stem Cell Transplant PatientsPublisher siteVaccines, Immune responses and vaccinations
14 Jun 2023Open access3cites
Venetoclax-azacitidine as salvage therapy for relapsed mixed phenotype acute leukemia after a second allogeneic hematopoietic stem cell transplantation: a case reportPublisher siteBlood Research, Acute Myeloid Leukemia Research
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Saloua?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you